Clinical Trials Browser

Interventional × Primary Breast Cancer × Doxorubicin × Clear all

NCT00793377 2008-11-19

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Phase 3 Completed

Primary Breast Cancer